MELONEX INJ

Each ml contains
Meloxicam. 5 mg
Excipients. Q.S.

Control of acute pain and inflammation, typically post-surgery.
Initial management of pain associated with trauma or acute injury.
Alleviation of pain and inflammation during acute flare-ups of osteoarthritis.
Reduction of fever in hospitalized companion animals.
Used as a transition treatment before switching to oral Meloxicam tablets.

Meloxicam is an NSAID that works by preferentially inhibiting the enzyme Cyclooxygenase-2 (COX-2). COX-2 is upregulated at sites of injury and inflammation, mediating the synthesis of pro-inflammatory prostaglandins. By blocking COX-2, Meloxicam effectively reduces the production of these mediators, thereby providing powerful analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effects. The injectable form ensures rapid systemic bioavailability, crucial for immediate post-operative pain management.

Rapid onset of action for immediate pain control, especially post-operative.
COX-2 selectivity aims to reduce gastrointestinal side effects.
Provides reliable 24 -hour coverage with a single daily injection.
Highly concentrated formula suitable for use in the clinical environment.
Reduces discomfort, promoting quicker recovery and mobility.

Dosage is strictly dictated by a veterinarian and based on the animal's weight.
Initial Dose (Dogs): 0.2 mg/kg body weight, as a single subcutaneous injection.
Initial Dose (Cats): Single dose of 0.3 mg/kg body weight, typically once only.
Method: Administer via subcutaneous (SC) or intravenous (IV) injection (veterinary discretion).
Transition: Follow-up treatment can be continued with the oral form at the maintenance dose.

Vial of 2 ml

Injection